{"id":75197,"date":"2012-05-31T23:17:47","date_gmt":"2012-05-31T23:17:47","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/scripps-research-institutes-richard-a-lerner-wins-prince-of-asturias-award-for-scientific-and-technical-research.php"},"modified":"2024-08-17T15:49:47","modified_gmt":"2024-08-17T19:49:47","slug":"scripps-research-institutes-richard-a-lerner-wins-prince-of-asturias-award-for-scientific-and-technical-research","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetic-engineering\/scripps-research-institutes-richard-a-lerner-wins-prince-of-asturias-award-for-scientific-and-technical-research.php","title":{"rendered":"Scripps Research Institute&#39;s Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research"},"content":{"rendered":"<p><p>    LA JOLLA, Calif., May 31, 2012 \/PRNewswire\/    --Scripps    Research Institute Professor Richard A. Lerner, MD, has    won a prestigious international honor, the Prince of Asturias    Award for Scientific and Technical Research, according to an    announcement made today by the Prince of Asturias Foundation. Lerner    shares the award with British biochemist Sir Gregory Winter, PhD.  <\/p>\n<p>    Sometimes called the \"Spanish Nobel Prize,\" the Prince of    Asturias Award for Scientific and Technical Research is    bestowed for findings that \"represent a significant    contribution to the progress and welfare of mankind.\" Winners    receive 50,000 Euros (about $62,000), a diploma, an insignia    bearing the foundation's coat of arms, and a sculpture    specially created for the awards by the late Spanish artist    Joan Miro.  <\/p>\n<p>    \"This honor for Richard is richly deserved,\" said Scripps Research    President and CEO Michael A. Marletta, PhD. \"His discoveries    have had a very significant impact on the treatment of disease    and I am delighted that this recognition has come to him.\"  <\/p>\n<p>    \"It is my honor to accept this prestigious award together with    Sir Greg,\" said Lerner, \"This is a wonderful recognition for    the field of immunochemistry and combinatorial antibody    libraries and all that they have contributed to human health.\"  <\/p>\n<p>    The announcement of the jury was broadcast live from Oviedo,    Spain, to more than 150 countries at noon, local time.  <\/p>\n<p>    The foundation's statement reads, \"The researchers Gregory    Winter and Richard A. Lerner stand at the forefront of research    on the immune system. The advances in the use of antibodies as    therapeutic tools have provided new ways of preventing and    treating immune disorders, degenerative diseases and different    types of tumours. In many cases, the use of antibodies has    alleviated the suffering of patients and has halted the    progression of the disease. These researchers have managed to    create a synthetic immune system in the test tube, as well as    demonstrating its preventive and therapeutic potential due to    exceeding the natural antibody repertoire the human body can    generate.\"  <\/p>\n<p>    This work has resulted in two drugs currently on the market, as    well as other compounds currently in clinical trials. The drug    Humira (adalimumab), marketed by Abbott, provides a treatment    for inflammatory diseases such as rheumatoid arthritis, Crohn's    disease, and plaque psoriasis. Humira is now reported to be    the top selling drug in the world.  <\/p>\n<p>    Benlysta (belimumab), which was developed by GlaxoSmithKline    and Human Genome Sciences, was approved in the United States    for the treatment of the most common type of lupusa chronic,    life-threatening autoimmune diseasein the spring of last year.    At that time, Benlysta became the first new drug for lupus in    50 years.  <\/p>\n<p>    41 Nominations This year, 41 nominations from    Argentina, Bulgaria, Canada, Costa Rica, Cuba, France, Germany,    Holland, Israel, Italy, Japan, Mexico, Russia, Sweden,    Switzerland, Turkey, United Kingdom, United States and Spain    were in the running for the Prince of Asturias Award for    Scientific and Technical Research. This prize is the fourth of    eight awards bestowed each year by the Prince of Asturias    Foundation. The others are in the fields of the arts,    communications and humanities, literature, sports, social    sciences, international cooperation, and concord (peace).  <\/p>\n<p>    The Prince of Asturias Foundation was founded in the city of    Oviedo on September 24, 1980, at a formal ceremony presided    over by His Royal Highness the Prince of Asturias, heir to the    throne of Spain, who was accompanied by his parents, Their    Majesties the King and Queen of Spain.  <\/p>\n<\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/scripps-research-institutes-richard-lerner-224700011.html;_ylt=A2KJjbwW_MdPfBYAxB__wgt.\" title=\"Scripps Research Institute&#39;s Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research\" rel=\"noopener\">Scripps Research Institute&#39;s Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> LA JOLLA, Calif., May 31, 2012 \/PRNewswire\/ --Scripps Research Institute Professor Richard A. Lerner, MD, has won a prestigious international honor, the Prince of Asturias Award for Scientific and Technical Research, according to an announcement made today by the Prince of Asturias Foundation. Lerner shares the award with British biochemist Sir Gregory Winter, PhD <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetic-engineering\/scripps-research-institutes-richard-a-lerner-wins-prince-of-asturias-award-for-scientific-and-technical-research.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[388386],"tags":[],"class_list":["post-75197","post","type-post","status-publish","format-standard","hentry","category-human-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/75197"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=75197"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/75197\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=75197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=75197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=75197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}